Alcista
$58.65
Precio del escenario
$56.660
+1.026 (+1.81%)Al cierre
British American Tobacco p.l.c. is a global multi-category consumer goods business company. The Company provides tobacco and nicotine products. Its segments include the United States, Asia Pacific Middle East and Africa, and Americas and Europe. Its product categories include Vapor, Heating Products (HPs), Modern Oral, Traditional Oral, and Combustibles. Vapor products are handheld, battery-powered devices that heat a liquid to produce an inhalable aerosol, known as vapor. HPs are devices that use heat to generate a nicotine-containing aerosol, which the user inhales. This category includes Tobacco Heated Products and Herbal Products for Heating (HPH). Modern Oral products are smoke-free oral nicotine products called nicotine pouches, designed for use in the mouth. Traditional oral products include snus and snuff. Its brands include Vuse, glo, Velo, Grizzly, Kent, Dunhill, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, Camel, and others.
British American Tobacco (BTI) is a good buy right now due to its attractive forward P/E ratio of 10.74, which indicates potential undervaluation compared to its earnings growth prospects. Additionally, the stock has a strong dividend yield of 6.3%, which is appealing for long-term investors seeking income. The current price of 55.5 is below the analyst price target of £58, suggesting room for price appreciation. However, a risk to consider is the 180.87% increase in hedge fund selling over the last quarter, indicating potential bearish sentiment among institutional investors.
Morgan Stanley
—
2026-09-07
Morgan Stanley
2026-09-07
Precio objetivo
—
UBS
—
2026-09-02
UBS
2026-09-02
Precio objetivo
—
RBC Capital
—
2026-08-11
RBC Capital
2026-08-11
Precio objetivo
—
BTIG
—
2026-07-21
BTIG
2026-07-21
Precio objetivo
—
Citi
—
2026-05-14
Citi
2026-05-14
Precio objetivo
—
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Three Undervalued Dividend Stocks to Consider

Four Dividend Stocks to Hold for the Next Decade

BTI Q2 2026 Earnings Call Transcript

BTI Q2 2026 Earnings Call Transcript

British American Tobacco Exceeds Half-Year Earnings Expectations
British American Tobacco p.l.c. is a global multi-category consumer goods business company. The Company provides tobacco and nicotine products. Its segments include the United States, Asia Pacific Middle East and Africa, and Americas and Europe. Its product categories include Vapor, Heating Products (HPs), Modern Oral, Traditional Oral, and Combustibles. Vapor products are handheld, battery-powered devices that heat a liquid to produce an inhalable aerosol, known as vapor. HPs are devices that use heat to generate a nicotine-containing aerosol, which the user inhales. This category includes Tobacco Heated Products and Herbal Products for Heating (HPH). Modern Oral products are smoke-free oral nicotine products called nicotine pouches, designed for use in the mouth. Traditional oral products include snus and snuff. Its brands include Vuse, glo, Velo, Grizzly, Kent, Dunhill, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, Camel, and others. It operates in the Consumer Non-Cyclicals sector (CIGARETTES industry).
British American Tobacco (BTI) is a good buy right now due to its attractive forward P/E ratio of 10.74, which indicates potential undervaluation compared to its earnings growth prospects. Additionally, the stock has a strong dividend yield of 6.3%, which is appealing for long-term investors seeking income. The current price of 55.5 is below the analyst price target of £58, suggesting room for price appreciation. However, a risk to consider is the 180.87% increase in hedge fund selling over the last quarter, indicating potential bearish sentiment among institutional investors.
2 analysts cover BTI: 2 rate it Buy, 0 Hold and 0 Sell.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.